Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of the Approximate Dose-Equivalent of Fibrinogen-to-Erythrocyte Suspension (ADEFES) Ratio on Mortality and Functional Outcomes in Patients With Major Intraoperative Bleeding- A Prospective Observational Trial (ADEFES Trial)

NCT06021184 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.

NCT NCT06021184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06021184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of the Approximate Dose-Equivalent of Fibrinogen-to-Erythrocyte Suspension (ADEFES) Ratio on Mortality and Functional Outcomes in Patients With Major Intraoperative Bleeding- A Prospective Observational Trial (ADEFES Trial)
Lead sponsor
Ankara City Hospital Bilkent
Phase
Observational
Overall status
Active, not recruiting
Start date
November 7, 2023
Completion date
September 30, 2026
Enrollment
1,679 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding during/following surgery, massive transfusion